India IVF Services Market by Gender (Female, Male, and Both [Combined]), Procedure (ICSI IVF, Non-ICSI IVF, and IUI), Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor Egg IVF Cycles), End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and Offering (IVF Drugs, IVF Reagents & Media, and IVF & IUI Services) - Opportunity Analysis and Industry Forecast, 2017-2023
- ALL1181292
- 50 Pages
- May 2017
- Healthcare
The India IVF services market was estimated $256 million in 2016 and is anticipated to reach $ 829.5 million by 2023 growing with a CAGR of 18.2% during the market forecast period of 2017 to 2023. The India IVF services market will experience significant growth due to increase in awareness among the population with respect to infertility and programs that are projected to develop patient confidence. Higher success rate of conception associated with IVF also accelerates the market growth. The demand drivers of the India IVF services market are high prevalence of infertility among population, change in lifestyle, growth in acceptance of ART and IVF and increase in awareness about IVF among the non-metro regions. However, the ethical and legal issues related to embryo transfer surrogacy possess as a major restrain to the market. Furthermore, lack of established regulations with respect to IVF also restricts the market growth. However, high potential for improvement of healthcare services in India presents lucrative opportunities for the overall development of the IVF services market in India.
The India IVF services market is segmented based on gender, procedure, offering, cycle type and end-user. The India IVF services market based on gender is classified into female infertility, male infertility and both (combined) infertility. The India IVF services market by procedure is categorized into intracytoplasmic sperm injection (ICSI-IVF), non ICSI-IVF and intrauterine insemination (IUI). The India IVF services market by offering includes drugs, media & reagents and services. The India IVF services market by cycle type is bifurcated into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. The India IVF services market by end-user is divided into fertility clinics, hospitals, surgical centers and clinical research institutes. The fertility clinics segment occupied the largest market share in the India IVF service market due to the availability and accessibility of different services related to IVF such as infertility treatment, IVF programs, egg donation, intracytoplasmic sperm injections (ICSI), intra-cytoplasmic morphologically selected sperm injections (IMSI) and others in these clinics. A thawed (non-donor) cycle is expected to be one of the most lucrative segments in the India IVF services market due to their wide applicability in IVF procedures.
The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes of the India IVF services market are Sun Pharmaceuticals Industries Ltd, Lab IVF Asia Pte. Ltd, LG Life Sciences, Cadila Pharmaceuticals Ltd, Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd, Southend Fertility & IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.), Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center, and others.
Key Benefits
- The study provides an in-depth analysis of the India IVF services market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2017 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on procedures assists in understanding the trends in the industry.
- Key market players are thoroughly analyzed to understand the competitive outlook of the industry.
India IVF Services Market Segments
By Gender
- Male
- Female
- Both (Combined)
- By Procedure
- ICSI IVF
- Non-ICSI IVF
- IUI
- By Cycle Type
- Fresh IVF Cycles
- Thawed IVF Cycles
- Donor Egg IVF Cycles
- By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- By Offering
- IVF Drugs
- IVF Media and Reagents
- IVF and IUI Services
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW
3.3. MARKET SIZE AND FORECAST
3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. KEY IMPACTING FACTORS
3.6.1. Drivers
3.6.1.1. Impact analysis of drivers
3.6.2. Restraints
3.6.2.1. Impact analysis of restraints
CHAPTER 4 INDIA IVF SERVICES MARKET, BY END USERS
4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. FERTILITY CLINICS
4.4. HOSPITALS
4.5. SURGICAL CENTERS
4.6. CLINICAL RESEARCH INSTITUTES
CHAPTER 5 INDIA IVF SERVICES MARKET, BY CYCLE TYPE
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. FRESH IVF CYCLES (NON-DONOR)
5.4. THAWED IVF CYCLES (NON-DONOR)
5.5. DONOR EGG IVF CYCLES
CHAPTER 6 COMPANY/HOSPITALS/CLINICS PROFILES
6.1. SUN PHARMACEUTICAL INDUSTRIES LTD.
6.1.1. Overview
6.2. TRIVECTOR ORIGIO SCIENTIFIC PVT. LTD
6.2.1. Overview
6.3. LABIVF ASIA PTE. LTD
6.3.1. Overview
6.4. LG LIFE SCIENCES
6.4.1. Overview
6.5. CADILA HEALTHCARE LTD. (ZYDUS CADILA GROUP)
6.5.1. Overview
6.6. BOURN HALL CLINIC
6.6.1. Overview
6.7. MORPHEUS IVF FERTILITY CENTER
6.7.1. Overview
6.8. SOUTHEND FERTILITY AND IVF CENTRE
6.8.1. Overview
6.9. NOVA IVI FERTILITY
6.9.1. Overview
6.10. BLOOM FERTILITY CENTER
6.10.1. Overview
6.11. MANIPAL ANKUR
6.11.1. Overview
6.12. CLOUDNINE
6.12.1. Overview
LIST OF TABLES
TABLE 1. INDIAN IVF SERVICES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
TABLE 2. INDIA IVF SERVICES MARKET, BY END USERS, 20142022 (THOUSAND CYCLES)
TABLE 3. INDIA IVF SERVICES MARKET, BY END USERS, 20142022 ($MILLION)
TABLE 4. INDIAN IVF SERVICES MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 5. INDIAN IVF SERVICES MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND CYCLES)
TABLE 6. SUN PHARMA: BUSINESS OVERVIEW
TABLE 7. TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEW
TABLE 8. LAB IVF ASIA BUSINESS OVERVIEW
TABLE 9. LG LIFE SCIENCE BUSINESS OVERVIEW
TABLE 10. CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 11. BOURN HALL CLINIC BUSINESS OVERVIEW
TABLE 12. MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
TABLE 13. SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEW
TABLE 14. NOVA IVI FERTILITY BUSINESS OVERVIEW
TABLE 15. MANIPAL ANKUR BUSINESS OVERVIEW
TABLE 16. CLOUDNINE BUSINESS OVERVIEW
LIST OF FIGURES
FIGURE 1. INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIGURE 2. INDIAN FERTILITY CLINICS IVF SERVICES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 3. INDIAN HOSPITALS IVF SERVICES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 4. INDIAN SURGICAL CENTERS IVF SERVICES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 5. INDIAN CLINICAL RESEARCH INSTITUTES IVF SERVICES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 6. INDIAN FRESH IVF CYCLES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 7. INDIAN THAWED IVF CYCLES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
FIGURE 8. INDIAN DONOR EGG IVF CYCLES MARKET, VOLUME (THOUSAND CYCLES) AND VALUE ($MILLION), 2014-2022
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
